Refine by
Degenerative Process Suppliers & Manufacturers
2 companies found
Technologybased in, NETHERLANDS
At veriNOS Pharmaceuticals, we focus on the clinical development of a drug that specifically inhibits a defined cascade that is relevant and common in different disease settings. The activation of iNOS with subsequent excessive production of cell ...
Ronopterin is an allosteric inhibitor of inducible NO synthase (iNOS) that rapidly decreases the excessive production of NO resulting from acute overactivation of this enzyme. Ronopterin has no significant effect on the physiological production of ...
Technologybased inCheshire, UNITED KINGDOM
Founded in 2012 at University of Manchester, Gelmetix is a UK medtech company focused on treating chronic lower back pain caused by the degeneration of the intervertebral discs. Gelmetix’s polymer gel technology also has the potential to be adapted ...
A focus on low-back pain. About 40% of chronic low-back pain is the result of degenerative disc disease3. Gelmetix’s double cross-linked microgel (DXM) is a biological solution that addresses the source of pain. In the intervertebral disc it ...